Integral Derivatives’s Aetna Inc AET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-32,100
Closed -$5.79M 1171
2017
Q4
$5.79M Buy
32,100
+30,200
+1,589% +$5.19M 0.11% 95
2017
Q3
$302K Sell
1,900
-16,500
-90% -$2.58M 0.01% 890
2017
Q2
$2.79M Sell
18,400
-2,200
-11% -$311K 0.06% 228
2017
Q1
$2.63M Sell
20,600
-31,500
-60% -$3.96M 0.05% 245
2016
Q4
$6.46M Buy
52,100
+31,800
+157% +$3.81M 0.12% 103
2016
Q3
$2.34M Buy
20,300
+3,800
+23% +$445K 0.05% 233
2016
Q2
$2.02M Buy
16,500
+1,500
+10% +$172K 0.05% 237
2016
Q1
$1.69M Buy
15,000
+10,000
+200% +$1.07M 0.06% 252
2015
Q4
$541K Sell
5,000
-18,000
-78% -$1.95M 0.01% 633
2015
Q3
$2.52M Buy
+23,000
New +$2.66M 0.07% 246
2015
Q2
Sell
-10,900
Closed -$1.16M 1338
2015
Q1
$1.16M Buy
+10,900
New +$1.07M 0.02% 463
2014
Q2
Sell
-4,000
Closed -$300K 1593
2014
Q1
$300K Sell
4,000
-700
-15% -$49.5K 0.01% 1055
2013
Q4
$322K Buy
+4,700
New +$307K ﹤0.01% 1192

Other funds holding AET

Integral Derivatives's AET Position: Q1 2018 in Review

Integral Derivatives sold out of Aetna Inc (AET) in Q1 2018, closing a stake of 25,962 shares — an estimated $4.67M sold.

Integral Derivatives first reported a position in AET in Q4 2014 and held it in 9 quarters. The position peaked at $4.68M in Q4 2017. 1,004 funds tracked by Wall St. Rank hold AET as of Q1 2018.

  • Integral Derivatives reported no remaining Aetna Inc position as of Q1 2018 after selling out during the quarter.
  • Integral Derivatives sold 25,962 Aetna Inc shares in Q1 2018, an estimated $4.67M.
  • Integral Derivatives first reported a position in Aetna Inc in Q4 2014 and held it in 9 quarters.
  • Integral Derivatives's Aetna Inc position peaked at $4.68M in Q4 2017.
  • 1,004 funds tracked by Wall St. Rank held Aetna Inc as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.